anastrozole
Abemaciclib Active in Early Breast Cancer
Results from a Phase II trial support further study of the CDK 4/6 inhibitor abemaciclib and anastrozole in ...
MARCH 17, 2017
Fulvestrant Over Anastrozole for Advanced Breast Cancer
As first-line single-agent hormone therapy, fulvestrant provides more durable disease control than anastrozole in ...
FEBRUARY 8, 2017
Side Effects of Hormonal Breast Cancer Therapy May Differ by Age
Age may exert a strong influence on AEs in long-term users of hormonal therapy in women.
JANUARY 6, 2016
Load more